Literature DB >> 8387074

Expression of basic fibroblast growth factor and its receptor in an invasive bladder carcinoma cell line.

L E Allen1, P A Maher.   

Abstract

Basic fibroblast growth factor (bFGF) is a multifunctional growth factor that can stimulate cell proliferation, production of proteases, and angiogenesis. Loss of mechanisms that regulate bFGF activity could result in tumor development. To test this idea, cells derived from an invasive bladder carcinoma (EJ) were compared with cells derived from a noninvasive bladder carcinoma (RT4) for the expression of bFGF and high and low affinity FGF receptors. bFGF was produced by the invasive EJ cells but not by the noninvasive RT4 cells, suggesting that bFGF could act in an autocrine fashion in the EJ cells to promote their invasion and growth in the surrounding tissue. The two cells lines also showed differences in FGF receptor expression. The EJ cells expressed both high and low affinity FGF receptors as determined by Scatchard analysis, whereas the RT4 cells expressed only high affinity receptors. The high affinity receptors on the RT4 cells were not recognized by an antibody to known FGF receptors. Furthermore, in contrast to the EJ cells, bFGF did not induce protein tyrosine phosphorylation in the RT4 cells. Thus these data suggest that the invasive potential of bladder carcinoma cells may be regulated by the expression of both bFGF and its receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387074     DOI: 10.1002/jcp.1041550218

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  18 in total

Review 1.  Muscle-invasive urothelial bladder cancer: an update on systemic therapy.

Authors:  Hayley Knollman; J Luke Godwin; Rishi Jain; Yu-Ning Wong; Elizabeth R Plimack; Daniel M Geynisman
Journal:  Ther Adv Urol       Date:  2015-12

2.  Effect of fibroblast growth factor saporin mitotoxins on human bladder cell lines.

Authors:  T A Tetzke; M C Caton; P A Maher; Z Parandoosh
Journal:  Clin Exp Metastasis       Date:  1997-11       Impact factor: 5.150

Review 3.  Targeting angiogenesis in bladder cancer.

Authors:  Aymen A Elfiky; Jonathan E Rosenberg
Journal:  Curr Oncol Rep       Date:  2009-05       Impact factor: 5.075

4.  Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells.

Authors:  M K Stachowiak; P A Maher; A Joy; E Mordechai; E K Stachowiak
Journal:  Mol Biol Cell       Date:  1996-08       Impact factor: 4.138

Review 5.  Growth factors in bladder cancer.

Authors:  M Liebert
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

6.  Upregulated MT1-MMP/TIMP-2 axis in the TSU-Pr1-B1/B2 model of metastatic progression in transitional cell carcinoma of the bladder.

Authors:  Christine L Chaffer; Bonnie Dopheide; Daniel R McCulloch; Allan B Lee; Jane M Moseley; Erik W Thompson; Elizabeth D Williams
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

7.  Enhanced gene expression of transforming growth factor-alpha and c-met in rat urinary bladder cancer.

Authors:  M Inui; N Nishi; A Yasumoto; I Takenaka; H Miyanaka; K Matsumoto; T Nakamura; F Wada
Journal:  Urol Res       Date:  1996

8.  Identification of soluble forms of the fibroblast growth factor receptor in blood.

Authors:  A Hanneken; W Ying; N Ling; A Baird
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-13       Impact factor: 11.205

Review 9.  The Cancer Immunogram as a Framework for Personalized Immunotherapy in Urothelial Cancer.

Authors:  Nick van Dijk; Samuel A Funt; Christian U Blank; Thomas Powles; Jonathan E Rosenberg; Michiel S van der Heijden
Journal:  Eur Urol       Date:  2018-09-28       Impact factor: 20.096

Review 10.  Molecular targets on the horizon for kidney and urothelial cancer.

Authors:  Joaquim Bellmunt; Bin T Teh; Giampaolo Tortora; Jonathan E Rosenberg
Journal:  Nat Rev Clin Oncol       Date:  2013-08-27       Impact factor: 66.675

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.